Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and Amylyx have seen similarly disappointing results.
Denali Suffers Another ALS Fail With Phase II/III Flop Read More »
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information regarding models’ development and maintenance.
FDA’s New AI Guidance Highlights Risks of Technology, Urges Early Sponsor Engagement Read More »
Noticias de la actualidad astronómica y astronáutica del 7 de enero de 2025. …
Antonio Gaudí, arquitecto catalán y figura emblemática del modernismo, dejó una huella indeleble en la historia de la arquitectura. Nacido en Reus, un pequeño municipio de Tarragona, Gaudí destacó por su capacidad de integrar elementos naturales, reli …
Antonio Gaudí: El visionario de la arquitectura modernista Read More »
En un mundo cada vez más preocupado por el cambio climático y la seguridad energética, Europa se encuentra en una encrucijada: ¿es posible alcanzar la autosuficiencia energética utilizando exclusivamente energías renovables? La respuesta es compleja, pero lo …
¿Podría Europa ser energéticamente autosuficiente con energías renovables? Read More »
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends Read More »
Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari Medical.
The FDA released the guidance in response to concerns that the devices are less accurate in people with darker skin pigmentation.
FDA issues much-anticipated guidance on pulse oximeters Read More »
The combined system stretches across seven states and includes 56 hospitals.
Marshfield Clinic Health System joins Sanford Health Read More »
The agency issued the alert as part of a pilot to improve the timeliness of communications about actions it believes are likely to be high-risk recalls.
FDA posts early alert about safety risk of Medline’s fluid delivery sets Read More »
